Donald E. Fetterolf, MD, discusses the major advantage of amniotic membrane therapy: the ability of the allografts to attract stem cells to the region of the wound in order to rebuild damaged tissues.
Charles M. Zelen, DPM, FACFAS, discusses some of the challenges of producing EpiFix, a leading dehydrated Human Amnion/Chorion Membrane (dHACM) allograft proven to be extremely effective at healing diabetic...
